Prescription drug · ANDA
buprenorphine transdermal system (Buprenorphine) NDC 64380-145
Buprenorphine 10 ug/1 · Patch, Extended release · Transdermal · Strides Pharma Science Limited
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 64380-145-02 | 6438001450264380014502 | 4 POUCH in 1 CARTON (64380-145-02) / 1 PATCH, EXTENDED RELEASE in 1 POUCH (64380-145-01)Marketed from Nov 16, 2026 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- buprenorphine transdermal system
- Generic name (nonproprietary)
- buprenorphine
- Active ingredients
- Buprenorphine — 10 ug/1
- Dosage form
- Patch, Extended release
- Route
- Transdermal
- Labeler
- Strides Pharma Science LimitedNDC labeler code 64380
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 207490
- Marketing start
- Listing expires
- DEA schedule
- CIII
- Other FDA classes
- Partial Opioid Agonists (Mechanism)
- Identifiers
- Product ID 64380-145_1a9a0478-c079-41a2-9662-c1616ce59e43SPL ID 1a9a0478-c079-41a2-9662-c1616ce59e43
- Pharmacologic class
- Partial Opioid Agonist
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Transdermal products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N464380014502followed by a unit qualifier and the quantityPackage 64380-0145-02. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
The FDA listing for this product does not reference a label (SPL) set.
About NDC 64380-145
- What is NDC 64380-145?
- 64380-145 is the product NDC for buprenorphine transdermal system (buprenorphine), Buprenorphine 10 ug/1 patch, extended release, listed with the FDA by Strides Pharma Science Limited. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- buprenorphine transdermal system (Buprenorphine).
- What is the active ingredient?
- Buprenorphine.
- Who is the labeler?
- Strides Pharma Science Limited, NDC labeler code 64380. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for buprenorphine transdermal system?
- 4 other product NDCs are listed under this name. See all buprenorphine transdermal system NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other buprenorphine transdermal system products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| buprenorphine transdermal systembuprenorphine | Buprenorphine 5 ug/h | Patch, Extended releaseTransdermal | Alvogen Inc. | 47781-406 | 47781-0406-04 |
| buprenorphine transdermal systembuprenorphine | Buprenorphine 10 ug/h | Patch, Extended releaseTransdermal | Alvogen Inc. | 47781-407 | 47781-0407-04 |
| buprenorphine transdermal systembuprenorphine | Buprenorphine 20 ug/h | Patch, Extended releaseTransdermal | Alvogen Inc. | 47781-408 | 47781-0408-04 |
| buprenorphine transdermal systembuprenorphine | Buprenorphine 15 ug/h | Patch, Extended releaseTransdermal | Alvogen Inc. | 47781-419 | 47781-0419-04 |
| buprenorphine transdermal systembuprenorphine | Buprenorphine 20 ug/h | Patch, Extended releaseTransdermal | LTS Therapy Systems, LLC | 58064-408 | 58064-0408-04 |
Other NDCs under ANDA 207490
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| buprenorphine transdermal systembuprenorphine | Buprenorphine 5 ug/h | Patch, Extended releaseTransdermal | Alvogen Inc. | 47781-406 |
| buprenorphine transdermal systembuprenorphine | Buprenorphine 10 ug/h | Patch, Extended releaseTransdermal | Alvogen Inc. | 47781-407 |
| buprenorphine transdermal systembuprenorphine | Buprenorphine 20 ug/h | Patch, Extended releaseTransdermal | Alvogen Inc. | 47781-408 |
| buprenorphine transdermal systembuprenorphine | Buprenorphine 15 ug/h | Patch, Extended releaseTransdermal | Alvogen Inc. | 47781-419 |
| buprenorphine transdermal systembuprenorphine | Buprenorphine 20 ug/h | Patch, Extended releaseTransdermal | LTS Therapy Systems, LLC | 58064-408 |